JB Chemicals and Pharmaceuticals Ltd

FDA Regulatory Profile

JB Chemicals and Pharmaceuticals Ltd appears in FDA public data with 3 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0520-2026, Class II) was initiated on April 23, 2026.

Summary

Total Recalls
3
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Known Names

jb chemicals and pharmaceuticals, j.b. chemicals and pharmaceuticals

Recent Recalls

NumberClassProductDate
D-0520-2026Class IIEnalapril Maleate Tablets, USP, 20 mg, 1,000-count bottle, Rx only, Manufactured by: Unique PharmaceApril 23, 2026
D-0032-2026Class IIICetirizine Hydrochloride Tablets USP 10 mg, 100 Tablets bottles, Manufactured by: Unique PharmaceutiSeptember 12, 2025
D-0033-2026Class IIICetirizine Hydrochloride Tablets USP 10 mg, 500 Tablets bottles, Manufactured by: Unique PharmaceutiSeptember 12, 2025